E2-CDS
Alternative Names: Brain-targeted estradiol - Teva Pharmaceutical Industries; E2CDS; EstredoxLatest Information Update: 16 Jan 2008
Price :
$50 *
At a glance
- Originator IVAX Corporation
- Class Estradiol congeners; Hormones
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Alzheimer's disease; Decreased libido; Vasomotor symptoms
Most Recent Events
- 16 Jan 2007 Discontinued - Phase-II for Vasomotor symptoms in USA (PO)
- 16 Jan 2007 Discontinued - Preclinical for Alzheimer's disease in USA (unspecified route)
- 16 Jan 2007 Discontinued - Preclinical for Decreased libido in USA (unspecified route)